Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 13, 2014, Pages 5365-5369

  Zeng, Wei Gen ^a   Zhou, Zhi Xiang ^a   Wang, Zheng ^a   Liang, Jian Wei ^a   Hou, Hui Rong ^a   Zhou, Hai Tao ^a   Zhang, Xing Mao ^a   Hu, Jun Jie ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Lymph lode ratio; Preoperative chemoradiation; Prognosis; Rectal cancer

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; CANCER STAGING; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RECTAL NEOPLASMS; RETROSPECTIVE STUDY; SURGERY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84905409139     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.13.5365     Document Type: Article

References (24)

1. Baxter NN, Virnig DJ, Rothenberger DA, et al (2005). Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst, 97, 219-25.
2. Chang GJ, Rodriguez-Bigas MA, Eng C, Skibber JM (2009). Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome. Cancer, 115, 5432-40.
3. Doll D, Gertler R, Maak M, et al (2009). Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance. World J Surg, 33, 340-7.
4. Gao C, Li JT, Fang L, Wen SW, Zhang L, Zhao HC (2013). Pre-operative predictive factors for intra-operative pathological lymph node metastasis in rectal cancers. Asian Pac J Cancer Prev, 14, 6293-9.
5. Goldstein NS, Sanford W, Coffey M, Layfield LJ (1996). Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol, 106, 209-16.
6. Greene FL, Stewart AK, Norton HJ (2002). A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50, 042 patients. Ann Surg, 236, 416-21.
7. Jin J, Li YX, Liu YP, et al (2006). A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer. Int J Radiat Oncol Biol Phys, 64, 725-9.
8. Kang J, Hur H, Min BS, Lee KY, Kim NK (2011). Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation. J Surg Oncol, 104, 53-8.
9. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al (2001). Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med, 34, 638-46.
10. Kim NK, Baik SH, Seong JS, et al (2006). Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer:Impact of postirradiated pathologic downstaging on local recurrence and survival. Ann Surg, 244, 1024-30.
11. Kim YW, Kim NK, Min BS, et al (2009). The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision. Ann Surg, 249, 965-72.
12. Klos CL, Bordeianou LG, Sylla P, Chang Y, Berger DL (2011). The prognostic value of lymph node ratio after neoadjuvant chemoradiation and rectal cancer surgery. Dis Colon Rectum, 54, 171-5.
13. La Torre M, Mazzuca F, Ferri M, et al (2013). The importance of lymph node retrieval and lymph node ratio following preoperative chemoradiation of rectal cancer. Colorectal Dis, 5, 382-8.
14. Lee SD, Kim TH, Kim DY, et al (2012). Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection. Eur J Surg Oncol, 38, 478-83.
15. Lee WC, Yusof MM, Lau FN, Phua VC (2013). Preoperative long course chemoirradiation in a developing country for rectal carcinoma: Kuala Lumpur hospital experience. Asian Pac J Cancer Prev, 14, 3941-4.
16. Madbouly KM, Abbas KS, Hussein AM (2013). Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study. Am J Surg, [Epub ahead of print].
17. Moug SJ, Saldanha JD, McGregor JR, Balsitis M, Diament RH (2009). Positive lymph node retrieval ratio optimises patient staging in colorectal cancer. Br J Cancer, 100, 1530-3.
18. Nadoshan JJ, Omranipour R, Beiki O, et al (2013). Prognostic value of lymph node ratios in node positive rectal cancer treated with preoperative chemoradiation. Asian Pac J Cancer Prev, 14, 3769-72.
19. Peschaud F, Benoist S, Julie C, et al (2008). The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg, 248, 1067-73.
20. Rosenberg R, Friederichs J, Schuster T, et al (2008). Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3, 026 patients over a 25-year time period. Ann Surg, 248, 968-78.
21. Rullier A, Laurent C, Capdepont M, et al (2008). Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma:number, status, and impact on survival. Am J Surg Pathol, 32, 45-50.
22. Sauer R, Becker H, Hohenberger W, et al (2004). Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 351, 1731-40.
23. Thorn CC, Woodcock NP, Scott N, et al (2004). What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis, 6, 356-61.
24. Wang H, Safar B, Wexner S, et al (2009). Lymph node harvest after proctectomy for invasive rectal adenocarcinoma following neoadjuvant therapy: does the same standard apply? Dis Colon Rectum, 52, 549-57.